| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 19.76 Billion | USD 59.53 Billion | 11.66% | 2024 |
FrequentlyAsked Questions
The global self-monitoring blood glucose devices market is expected to grow due to rising prevalence of diabetes, increasing health awareness, and demand for portable, real-time glucose monitoring solutions.
According to a study, the global self-monitoring blood glucose devices market size was worth around USD 19.76 Billion in 2024 and is expected to reach USD 59.53 Billion by 2034.
The global self-monitoring blood glucose devices market is expected to grow at a CAGR of 11.66% during the forecast period.
North America is expected to dominate the self-monitoring blood glucose devices market over the forecast period.
Leading players in the global self-monitoring blood glucose devices market include Abbott Laboratories, Dexcom, Medtronic, Roche, Ascensia Diabetes Care, Senseonics, Nemaura Medical, Know Labs, BioXensor, DiaMonTech, among others.
The report explores crucial aspects of the self-monitoring blood glucose devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients